...
首页> 外文期刊>The American Journal of Cardiology >Prevalence of and risk factors for silent ischemic stroke in patients with atrial fibrillation as determined by brain magnetic resonance imaging
【24h】

Prevalence of and risk factors for silent ischemic stroke in patients with atrial fibrillation as determined by brain magnetic resonance imaging

机译:通过脑磁共振成像确定的房颤患者无症状性缺血性卒中的患病率和危险因素

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Varied silent ischemic stroke (SS) prevalence occurs in patients with atrial fibrillation (AF). Stroke history is worth 2 points in the CHADS 2 scoring system. An unknown proportion of patients with AF with a CHADS2 score of 0 or 1 have been undertreated for stroke prevention. We investigated SS risk factors using magnetic resonance imaging and estimated SS impact on clinical outcomes in patients with AF. We analyzed a total of 1,200 patients (400 with AF and 800 with sinus rhythm) who had brain magnetic resonance imaging performed for routine health checkups. Clinical outcomes including symptomatic stroke, dementia, and cognitive disorder were also evaluated in patients with AF (follow-up duration: 66.7 ± 35.9 months; range 10 to 162). SS was observed in 113 patients with AF (28.3%), which was significantly higher than that in 53 subjects (6.6%) with sinus rhythm (p 0.001, odds ratio [OR] 5.549). Independent risk factors for SS in patients with AF were age (OR 1.049), hypertension (OR 2.086), dyslipidemia (OR 2.073), and valvular AF (OR 3.157). Symptomatic stroke incidence during the follow-up was significantly greater in patients with AF with SS than without SS (5.6% vs 2.7% per year, respectively; p = 0.022, hazard ratio 1.787, 95% confidence interval 1.089 to 2.933). Using current scoring systems without correcting for subclinical stroke, clinicians have likely underestimated the stroke risk in low-risk patients with AF; thus many patients with AF might not receive optimal anticoagulation treatment. In conclusion, a screening tool for detecting SS could be considered for stroke risk evaluation in patients with AF, especially those with valvular AF, elderly patients, and patients with dyslipidemia or hypertension.
机译:房颤(AF)患者发生各种沉默性缺血性卒中(SS)患病率。在CHADS 2评分系统中,中风历史记录值得2分。 CHADS2评分为0或1的房颤患者中,未知比例的患者因卒中预防而未得到充分治疗。我们使用磁共振成像调查了SS危险因素,并估计了SS对AF患者临床结局的影响。我们分析了总共1200例患者(400例AF和800例窦性心律),他们进行了脑磁共振成像检查以进行常规健康检查。房颤患者还评估了包括有症状中风,痴呆和认知障碍在内的临床结局(随访时间:66.7±35.9个月;范围10至162)。在113例AF患者中观察到SS(28.3%),明显高于53例窦性心律患者(p <0.001,优势比[OR] 5.549)。 AF患者SS的独立危险因素为年龄(OR 1.049),高血压(OR 2.086),血脂异常(OR 2.073)和瓣膜性AF(OR 3.157)。伴SS的房颤患者在随访期间的症状性卒中发生率显着高于未伴SS的房颤患者(分别为5.6%和2.7%,每年; p = 0.022,危险比1.787,95%置信区间1.089至2.933)。使用当前的评分系统而不校正亚临床卒中,临床医生可能低估了低危房颤患者的卒中风险。因此,许多房颤患者可能无法获得最佳的抗凝治疗。总之,对于房颤患者,尤其是瓣膜性房颤患者,老年患者,血脂异常或高血压患者,可以考虑使用一种用于检测SS的筛查工具进行卒中风险评估。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号